You have 9 free searches left this month | for more free features.

City

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Telix International Pty Ltd (1)

Collaborator

Intervention

89zr-dfo-girentuximab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

89zr-dfo-girentuximab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

Not yet recruiting

Cervical Cancer
+13 more

89Zr-DFO-girentuximab

(no location specified)

Sep 28, 2022